PL1961761T3 - Oligomeryczne amidoaminy lub amidokwaty do kompozycji do obróbki tkanin lub włosów - Google Patents

Oligomeryczne amidoaminy lub amidokwaty do kompozycji do obróbki tkanin lub włosów

Info

Publication number
PL1961761T3
PL1961761T3 PL06833631T PL06833631T PL1961761T3 PL 1961761 T3 PL1961761 T3 PL 1961761T3 PL 06833631 T PL06833631 T PL 06833631T PL 06833631 T PL06833631 T PL 06833631T PL 1961761 T3 PL1961761 T3 PL 1961761T3
Authority
PL
Poland
Prior art keywords
wilms
tumor
peptide compounds
novel peptide
novel
Prior art date
Application number
PL06833631T
Other languages
English (en)
Inventor
Toshio Nishihara
Masashi Gotoh
Original Assignee
Int Inst Cancer Immunology Inc
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Inst Cancer Immunology Inc, Sumitomo Dainippon Pharma Co Ltd filed Critical Int Inst Cancer Immunology Inc
Publication of PL1961761T3 publication Critical patent/PL1961761T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001152—Transcription factors, e.g. SOX or c-MYC
    • A61K39/001153—Wilms tumor 1 [WT1]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06833631T 2005-11-30 2006-11-29 Oligomeryczne amidoaminy lub amidokwaty do kompozycji do obróbki tkanin lub włosów PL1961761T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005346577 2005-11-30
EP06833631A EP1961761B1 (en) 2005-11-30 2006-11-29 Novel peptide compounds from wilms' tumor
PCT/JP2006/323827 WO2007063903A1 (ja) 2005-11-30 2006-11-29 新規ペプチド化合物

Publications (1)

Publication Number Publication Date
PL1961761T3 true PL1961761T3 (pl) 2011-04-29

Family

ID=38092236

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06833631T PL1961761T3 (pl) 2005-11-30 2006-11-29 Oligomeryczne amidoaminy lub amidokwaty do kompozycji do obróbki tkanin lub włosów

Country Status (18)

Country Link
US (4) US7939627B2 (pl)
EP (1) EP1961761B1 (pl)
JP (4) JP4394724B2 (pl)
KR (1) KR101385805B1 (pl)
CN (2) CN105315347A (pl)
AU (1) AU2006319892B2 (pl)
BR (1) BRPI0619255B8 (pl)
CA (1) CA2631292C (pl)
DE (1) DE602006017880D1 (pl)
DK (1) DK1961761T3 (pl)
ES (1) ES2352855T3 (pl)
HK (1) HK1221230A1 (pl)
PL (1) PL1961761T3 (pl)
PT (1) PT1961761E (pl)
RU (1) RU2424247C2 (pl)
SI (1) SI1961761T1 (pl)
TW (1) TWI372152B (pl)
WO (1) WO2007063903A1 (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101213015B1 (ko) 2003-11-05 2012-12-26 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Ｗｔ１ 로부터 유도된 ｈｌａ-ｄｒ 결합성 항원 펩티드
EP1951281B1 (en) 2005-10-17 2015-04-15 Sloan Kettering Institute For Cancer Research Wt1 hla class ii-binding peptides and compositions and methods comprising same
CA2631292C (en) 2005-11-30 2014-05-06 International Institute Of Cancer Immunology, Inc. Derivatised wt1 cancer antigen peptides and their use
WO2007120673A2 (en) 2006-04-10 2007-10-25 Sloan Kettering Institute For Cancer Research Immunogenic wt-1 peptides and methods of use thereof
BRPI0808084A2 (pt) 2007-02-27 2014-07-22 Int Inst Cancer Immunology Inc Método para ativação de células t auxiliadoras e composição para uso no método.
JP2011016751A (ja) * 2009-07-08 2011-01-27 Sumitomo Chemical Co Ltd 光学活性３−アミノピペリジン−１−カルボキシレート化合物の製造方法およびその製造方法に用いられる中間体
ES2757591T3 (es) 2010-03-31 2020-04-29 Stabilitech Biopharma Ltd Estabilización de partículas virales
WO2011121301A1 (en) 2010-03-31 2011-10-06 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material
CA2795050C (en) 2010-03-31 2018-05-22 Stabilitech Ltd. Method for preserving alum adjuvants and alum-adjuvanted vaccines
KR20140009168A (ko) 2010-10-05 2014-01-22 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 헬퍼 ｔ 세포의 활성화 방법
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
US9539299B2 (en) * 2011-10-27 2017-01-10 International Institute Of Cancer Immunology, Inc. Combination therapy with WT1 peptide vaccine and temozolomide
AU2013207669C1 (en) 2012-01-13 2018-05-31 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
JP6163486B2 (ja) 2012-07-02 2017-07-12 大日本住友製薬株式会社 癌抗原ペプチド経皮剤
CN104853764B (zh) * 2012-12-13 2018-06-22 海德堡吕布莱希特-卡尔斯大学 用于预防和治疗癌症的msi-特异性移码肽(fsp)
SG10201705028WA (en) 2012-12-17 2017-07-28 Otsuka Pharma Co Ltd Method for activating helper t cell
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
RS61173B1 (sr) * 2013-01-15 2021-01-29 Memorial Sloan Kettering Cancer Center Imunogeni wt-1 peptidi i postupci za njihovu upotrebu
KR102050931B1 (ko) 2013-02-05 2019-12-02 닛토덴코 가부시키가이샤 경피 투여용 ｗｔ1 펩티드 암 백신 테이프제
RU2687026C2 (ru) 2013-02-05 2019-05-06 Нитто Денко Корпорейшн Вакцинная композиция против злокачественной опухоли на основе пептида wt1 для мукозального введения
KR20140100419A (ko) 2013-02-05 2014-08-14 닛토덴코 가부시키가이샤 경피 투여용 ｗｔ1 펩티드 암 백신 조성물
EP2762152A1 (en) 2013-02-05 2014-08-06 Nitto Denko Corporation WT1 peptide cancer vaccine composition for transdermal administration
WO2014136814A1 (ja) 2013-03-08 2014-09-12 大鵬薬品工業株式会社 新規ｃｔｌエピトープ５連結ペプチド
EP2974734B1 (en) 2013-03-12 2018-10-10 Sumitomo Dainippon Pharma Co., Ltd. Liquid aqueous composition
SG11201507883SA (en) 2013-03-29 2015-10-29 Sumitomo Dainippon Pharma Co Ltd Wt1-antigen peptide conjugate vaccine
WO2014157704A1 (ja) 2013-03-29 2014-10-02 大日本住友製薬株式会社 Ｅｒａｐ１によるトリミング機能をきっかけとしたコンジュゲートワクチン
PT3061771T (pt) 2013-10-21 2020-05-06 Taiho Pharmaceutical Co Ltd Novo péptido unido a quatro epitopos ctl
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
ES2916834T3 (es) 2014-09-27 2022-07-06 Sumitomo Pharma Co Ltd Composición farmacéutica para inyección
JP6671141B2 (ja) * 2014-10-21 2020-03-25 大日本住友製薬株式会社 懸濁液剤
JP6699013B2 (ja) * 2014-12-25 2020-05-27 国立大学法人三重大学 Ｗｔ１由来ペプチド認識抗体
US12383608B2 (en) 2016-11-30 2025-08-12 Sumitomo Pharma Co., Ltd. WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides
JPWO2018181648A1 (ja) 2017-03-30 2020-02-13 大日本住友製薬株式会社 Ｗｔ１癌抗原ペプチドおよびこれを含むペプチドコンジュゲート体
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
TWI805792B (zh) 2018-06-29 2023-06-21 日商大鵬藥品工業股份有限公司 抗腫瘤劑及其評估方法
JP7162675B2 (ja) 2018-09-28 2022-10-28 住友ファーマ株式会社 注射用組成物
CA3115240A1 (en) 2018-10-05 2020-04-09 International Institute Of Cancer Immunology, Inc. Composition for preventing or treating benign tumor
JP7432531B2 (ja) * 2019-02-13 2024-02-16 住友ファーマ株式会社 システイン残基を有するヘミアスタリン誘導体
WO2020204173A1 (ja) 2019-04-05 2020-10-08 大日本住友製薬株式会社 水溶性アジュバントおよびそれを含有する組成物
CN113966326A (zh) 2019-04-05 2022-01-21 大日本住友制药株式会社 水溶性佐剂
JP7153287B2 (ja) 2020-05-12 2022-10-14 住友ファーマ株式会社 癌を処置するための医薬組成物
MX2024001843A (es) 2021-08-12 2024-05-16 Int Inst Cancer Immunology Inc Composición farmacéutica y método para tratar o prevenir cáncer.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858358A (en) * 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
US6297041B1 (en) * 1992-03-11 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6309642B1 (en) * 1997-04-28 2001-10-30 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
US5858682A (en) * 1996-08-02 1999-01-12 Pharmingen E2A/pbx1 fusion protein specific monoclonal antibodies
AU4932199A (en) * 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
AR021849A1 (es) * 1998-09-30 2002-08-07 Corixa Corp Composiciones y metodos para la inmunoterapia especifica de wt1
GB9823897D0 (en) 1998-11-02 1998-12-30 Imp College Innovations Ltd Immunotherapeutic methods and molecules
US7534605B2 (en) * 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
EP1371664B1 (en) 2001-03-22 2008-01-09 International Institute of Cancer Immunology, Inc. Wti modified peptide
EP1379272B1 (en) * 2001-04-17 2010-01-20 Novartis Vaccines and Diagnostics, Inc. Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes
JP5230891B2 (ja) * 2001-09-28 2013-07-10 株式会社癌免疫研究所 抗原特異的ｔ細胞の新規な誘導方法
US20050002951A1 (en) * 2001-09-28 2005-01-06 Haruo Sugiyama Novel method of inducing antigen-specific t cells
WO2003106682A1 (ja) * 2002-06-12 2003-12-24 中外製薬株式会社 Ｈｌａ−ａ２４拘束性癌抗原ペプチド
WO2004024175A1 (ja) 2002-09-12 2004-03-25 Haruo Sugiyama 癌抗原ペプチド製剤
ES2331305T3 (es) * 2002-09-20 2009-12-29 International Institute Of Cancer Immunology, Inc. Peptidos de wt1 de tipo sustituido.
CA2513366A1 (en) * 2003-01-13 2004-07-29 Richard Wodzianek Host extensible wireless application interface
ES2332590T3 (es) * 2003-01-15 2010-02-09 International Institute Of Cancer Immunology, Inc. Dimero peptidico.
WO2005001117A1 (ja) * 2003-06-27 2005-01-06 Haruo Sugiyama Ｗｔ１ワクチン適応患者の選択方法
KR101213015B1 (ko) * 2003-11-05 2012-12-26 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Ｗｔ１ 로부터 유도된 ｈｌａ-ｄｒ 결합성 항원 펩티드
WO2005065382A2 (en) * 2003-12-31 2005-07-21 University Of Rochester Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
PT1731605E (pt) 2004-03-31 2010-04-14 Int Inst Cancer Immunology Inc Péptidos antigénicos de cancro derivados de wt1
WO2005121178A2 (en) * 2004-06-08 2005-12-22 Wisconsin Alumni Research Foundation Immunoaffinity chromatography polyol-responsive monoclonal antibodies
CA2631292C (en) * 2005-11-30 2014-05-06 International Institute Of Cancer Immunology, Inc. Derivatised wt1 cancer antigen peptides and their use

Also Published As

Publication number Publication date
JP4394724B2 (ja) 2010-01-06
CA2631292A1 (en) 2007-06-07
US20140046036A1 (en) 2014-02-13
CN105315347A (zh) 2016-02-10
CA2631292C (en) 2014-05-06
US9765114B2 (en) 2017-09-19
JP2012158597A (ja) 2012-08-23
JP2009286792A (ja) 2009-12-10
US20160168197A1 (en) 2016-06-16
RU2424247C2 (ru) 2011-07-20
BRPI0619255A8 (pt) 2015-12-15
KR101385805B1 (ko) 2014-04-16
EP1961761B1 (en) 2010-10-27
KR20080073356A (ko) 2008-08-08
US9273148B2 (en) 2016-03-01
BRPI0619255B8 (pt) 2021-05-25
JP5597668B2 (ja) 2014-10-01
ES2352855T3 (es) 2011-02-23
DE602006017880D1 (pl) 2010-12-09
JP2014080435A (ja) 2014-05-08
JPWO2007063903A1 (ja) 2009-05-07
RU2008126305A (ru) 2010-01-10
CN101336249A (zh) 2008-12-31
PT1961761E (pt) 2010-12-16
US7939627B2 (en) 2011-05-10
BRPI0619255B1 (pt) 2021-05-11
TW200730540A (en) 2007-08-16
US8575308B2 (en) 2013-11-05
EP1961761A4 (en) 2009-01-21
JP5049323B2 (ja) 2012-10-17
EP1961761A1 (en) 2008-08-27
DK1961761T3 (da) 2010-11-29
JP5800928B2 (ja) 2015-10-28
HK1221230A1 (zh) 2017-05-26
BRPI0619255A2 (pt) 2011-09-27
SI1961761T1 (sl) 2010-12-31
AU2006319892A1 (en) 2007-06-07
AU2006319892B2 (en) 2012-05-10
US20110229506A1 (en) 2011-09-22
US20100062010A1 (en) 2010-03-11
TWI372152B (en) 2012-09-11
HK1122819A1 (en) 2009-05-29
WO2007063903A1 (ja) 2007-06-07

Similar Documents

Publication Publication Date Title
PL1961761T3 (pl) Oligomeryczne amidoaminy lub amidokwaty do kompozycji do obróbki tkanin lub włosów
IL246171A0 (en) Peptide-based compounds
EP1824976A4 (en) ANTIMICROBIAL PEPTIDES
IL183513A0 (en) Triazole substituted aminobenzophenone compounds
IL172429A0 (en) Novel aminobenzophenone compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
EP1817046A4 (en) NEW ANTIMICROBIAL PEPTIDES
EP1648885A4 (en) NEW CONNECTIONS
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
SI1828148T1 (sl) S triazolom nadomeĺ äśeni aminobenzofenonski sestavki
GB0418182D0 (en) Compound libraries 14
GB0413812D0 (en) Compound libraries 9
GB0414058D0 (en) Compound libraries 12
GB0418183D0 (en) Compound libraries 15
SI1658263T1 (sl) Nove spojine aminobenzofenona
GB0301955D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0301591D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds
GB0301608D0 (en) Novel compounds
GB0301872D0 (en) Novel compounds